| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/12/2007 | US20070161597 A time-release formulation of a water-soluble derivative having the fatty acid moiety removed and an antiinflammatory agent; opoid resistant neuropathic pain, amputation pain or neuralgia; |
| 07/12/2007 | US20070161583 increasing patient compliance in treatment of hepatitis-C virus infection; tablets; blister packs |
| 07/12/2007 | US20070161571 Prevents the aggregation of LHRH antagonists in solutions; bioavailability |
| 07/12/2007 | US20070161564 Methods for making Apo-2 ligand using divalent metal ions |
| 07/12/2007 | US20070161563 A device for enhanced epithelial permeation of y2 receptor-binding peptides |
| 07/12/2007 | US20070161063 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/12/2007 | US20070160678 Microcapsules with modified release of active principles with low solubility for oral delivery |
| 07/12/2007 | US20070160677 Encapsulation of lipid-based formulations in enteric polymers |
| 07/12/2007 | US20070160676 Stable dispersion of DBNPA in viscosified brine |
| 07/12/2007 | US20070160675 Preferably cefdinir, in rapid dissolving tablets that release the drug a bimodal, multimodal or continuous manner |
| 07/12/2007 | US20070160674 Method for producing calcium component powder containing oil-soluble substance |
| 07/12/2007 | US20070160673 Amoxicilline instant granulate |
| 07/12/2007 | US20070160672 Methods of making bioabsorbable drug delivery devices comprised of solvent cast films |
| 07/12/2007 | US20070160671 Biguanide formulations |
| 07/12/2007 | US20070160670 Compression-coated tablets and manufacture thereof |
| 07/12/2007 | US20070160669 Delayed release carnitine |
| 07/12/2007 | US20070160668 Prolonged release bioadhesive therapeutic systems |
| 07/12/2007 | US20070160667 Controlled release formulation of divalproex sodium |
| 07/12/2007 | US20070160666 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; free of ascorbic acid and pregelatinized starch; for treatment of atheroslerosis; stability |
| 07/12/2007 | US20070160665 Chlorthalidone combinations |
| 07/12/2007 | US20070160664 Pharmaceutical compositions comprising of proton pump inhibitor and prokinetic agent |
| 07/12/2007 | US20070160663 Single unit pharmaceutical composition comprising a mixture of fenofibrate and a modified release form of a homocysteine reducing agent |
| 07/12/2007 | US20070160662 Method and apparatus for blowmoding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules |
| 07/12/2007 | US20070160661 Aspirin formulation for cardiovascular health |
| 07/12/2007 | US20070160660 solid dietary and/or nutraceutic pharmaceutical compositions for oral use based on S-adenosylmethionine, or salts thereof, in combination with inositol and/or derivatives thereof with the addition of magnesium oxide as stabilizer |
| 07/12/2007 | US20070160659 Stabilized formulations of phosphatidylserine |
| 07/12/2007 | US20070160658 Delivery system for diagnostic and therapeutic agents |
| 07/12/2007 | US20070160657 Targeting and intestinal-absorption controlled liposome having sugar chain and therapeutic drug for cancer and diagnostic drug containing the liposome |
| 07/12/2007 | US20070160656 Lipid platinum complexes and methods of use thereof |
| 07/12/2007 | US20070160653 Hemostatic textile |
| 07/12/2007 | US20070160652 Microemulsions |
| 07/12/2007 | US20070160651 Nanoemulsions |
| 07/12/2007 | US20070160648 Methods for treating otic disorders |
| 07/12/2007 | US20070160647 Materials for medical implants and occlusive devices |
| 07/12/2007 | US20070160572 Colloidal metal compositions and methods |
| 07/12/2007 | US20070160567 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 07/12/2007 | US20070160556 Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant |
| 07/12/2007 | US20070160543 Haemostatic sprays and compositions |
| 07/12/2007 | US20070160541 Bronchodilating beta-agonist compositions and methods |
| 07/12/2007 | US20070160531 Targeting endothelium for tissue-specific delivery of agents |
| 07/12/2007 | US20070158266 Method And Apparatus For Producing Particles Via Supercritical Fluid Processing |
| 07/12/2007 | US20070158227 Plaster enclosing packaging bag |
| 07/12/2007 | DE4208258B4 Verfahren zur Herstellung von kristallinem Ciclosporin in kugelartiger Teilchenform und seine Verwendung, insbesondere zur pulmonalen Verabreichung A process for producing crystalline Ciclosporin in spheroidal particulate form and to its use, in particular for pulmonary administration |
| 07/12/2007 | DE102006001199A1 Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans Fixed combination of substances with the addition of defoamers for use as Darmspüllösung and / or laxative |
| 07/12/2007 | DE102005060461A1 Medizinische Zusammensetzung A medical composition |
| 07/12/2007 | DE10045904B4 alpha-Liponsäure(-Derivate) enthaltende Retardform alpha-lipoic acid (derivatives) containing sustained release form |
| 07/12/2007 | CA2841386A1 Extended release of neuregulin for improved cardiac function |
| 07/12/2007 | CA2643064A1 Oral, pulmonary and transmucosal delivery composition |
| 07/12/2007 | CA2640889A1 Pharmaceutical composition for the treatment of nail diseases |
| 07/12/2007 | CA2636210A1 Pack |
| 07/12/2007 | CA2635994A1 Drug delivery system for bioadhesion to a vulvovaginal surface |
| 07/12/2007 | CA2635992A1 Medicament for topical use |
| 07/12/2007 | CA2635986A1 Composition and method of use thereof |
| 07/12/2007 | CA2635610A1 Extracts of chenopodium ambrosioides l., the compositions comprising said extracts, the preparing process and application thereof |
| 07/12/2007 | CA2635594A1 Gastric release pulse system for drug delivery |
| 07/12/2007 | CA2635566A1 Adhesively bonded dosage form |
| 07/12/2007 | CA2635466A1 Gastric retentive gabapentin dosage forms and methods for using same |
| 07/12/2007 | CA2635337A1 Device for treating the anal sphincter |
| 07/12/2007 | CA2634993A1 Concentrated liquid thyroid hormone composition |
| 07/12/2007 | CA2634685A1 Novel hair treatment compositions |
| 07/12/2007 | CA2634376A1 Adhesive patch |
| 07/12/2007 | CA2634272A1 Adhesive patch and production method thereof |
| 07/12/2007 | CA2634160A1 Disintegrating loadable tablets |
| 07/12/2007 | CA2633599A1 Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers |
| 07/12/2007 | CA2630235A1 Lansoprazole orally disintegrating tablets |
| 07/12/2007 | CA2627684A1 Metaxalone formulations and methods for the preparation thereof |
| 07/11/2007 | EP1806367A2 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/11/2007 | EP1806361A1 Erythropoietin liquid formulation |
| 07/11/2007 | EP1806354A2 Amphoteric sterols and their use |
| 07/11/2007 | EP1806152A1 Drug for external use and adhesive patch |
| 07/11/2007 | EP1806151A1 Drug for external use and adhesive patch |
| 07/11/2007 | EP1806149A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 07/11/2007 | EP1806133A1 Method for modifying the ambience, and spray liquid and sprayer used in the method |
| 07/11/2007 | EP1806130A1 Solid pharmaceutical composition comprising irbesartan |
| 07/11/2007 | EP1806129A1 Composition containing fine particles and process for producing the same |
| 07/11/2007 | EP1806057A1 Micro pellets for the preparation of animal feed pellets |
| 07/11/2007 | EP1806056A1 Particles including sensitive component |
| 07/11/2007 | EP1804855A2 Flow regulator |
| 07/11/2007 | EP1804813A2 Formulations and methods for treatment of inflammatory diseases |
| 07/11/2007 | EP1804787A2 Flavonoid composition for treating oral diseases |
| 07/11/2007 | EP1804777A1 Pharmaceutical composition comprising diclofenac |
| 07/11/2007 | EP1804774A1 Disintegrating buccal tablets |
| 07/11/2007 | EP1804773A2 Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| 07/11/2007 | EP1804772A1 Granules comprising a nsaid and a sugar alcohol made by melt extrusion |
| 07/11/2007 | EP1804771A2 Compositions for controlled delivery of pharmaceutically active compounds |
| 07/11/2007 | EP1804770A2 Lubricious compounds for biomedical applications using hydrophilic polymers |
| 07/11/2007 | EP1804769A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 07/11/2007 | EP1804768A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 07/11/2007 | EP1804767A2 Biocompatible drug delivery apparatus and methods |
| 07/11/2007 | EP1804766A2 Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same |
| 07/11/2007 | EP1804765A2 Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| 07/11/2007 | EP1804764A1 A highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a powder and a freezedrying step |
| 07/11/2007 | EP1804751A2 Ocular delivery of polymeric delivery formulations |
| 07/11/2007 | EP1804674A2 A method for protecting implantable sensors and protected implantable sensors |
| 07/11/2007 | EP1804579A1 Process for making antimicrobial polymer articles |
| 07/11/2007 | EP1741425A4 Novel antiviral pharmaceutical composition |
| 07/11/2007 | EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/11/2007 | EP1458398A4 Antibiotic formulation and a method of making this formulation |
| 07/11/2007 | EP1383816B1 Film-forming composition for topical use and use thereof for delivering active agents |
| 07/11/2007 | EP1345549A4 Dispensing device |